NeuroBo Pharmaceuticals, Inc. - stock earnings
NRBO Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q3 | -3.8 million USD | ? USD |
2023Q2 | -734000 USD | ? USD |
2023Q1 | -2.7 million USD | ? USD |
2022Q4 | 994000 USD | ? USD |
2022Q3 | -3.1 million USD | ? USD |
2022Q2 | -3.4 million USD | ? USD |
2022Q1 | -2.9 million USD | ? USD |
2021Q4 | -4.6 million USD | ? USD |
2021Q3 | -3.5 million USD | ? USD |
2021Q2 | -3.9 million USD | ? USD |
2021Q1 | -19.5 million USD | ? USD |
2020Q4 | -29.7 million USD | ? USD |
2020Q3 | -3.1 million USD | ? USD |
2020Q2 | -2.4 million USD | ? USD |
2020Q1 | -4.7 million USD | ? USD |
2019Q4 | -11.2 million USD | ? USD |
2019Q3 | -3.4 million USD | ? USD |
2019Q2 | -2.9 million USD | ? USD |
2019Q1 | -3.8 million USD | ? USD |
2018Q4 | -3.7 million USD | ? USD |
2018Q3 | -6.1 million USD | ? USD |
2018Q2 | -6.7 million USD | ? USD |
2018Q1 | -7.2 million USD | ? USD |
2017Q4 | -6.7 million USD | ? USD |
2017Q3 | -8.7 million USD | ? USD |
2017Q2 | -10.5 million USD | ? USD |
2017Q1 | -7.5 million USD | ? USD |
2016Q4 | -7.2 million USD | ? USD |
2016Q3 | -3.9 million USD | ? USD |
2016Q2 | -1.4 million USD | ? USD |
2016Q1 | -2.1 million USD | ? USD |
2015Q4 | -2.6 million USD | ? USD |
2015Q3 | -2.6 million USD | ? USD |
2015Q2 | -1.6 million USD | ? USD |
2015Q1 | -2.3 million USD | ? USD |
NRBO Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -11.8 million USD | ? USD |
2022 | -6.1 million USD | ? USD |
2021 | -15.2 million USD | ? USD |
2020 | -29.6 million USD | ? USD |
2019 | -22.4 million USD | ? USD |
2018 | -23.6 million USD | ? USD |
2017 | -33.4 million USD | ? USD |
2016 | -14.6 million USD | ? USD |
2015 | -9.0 million USD | ? USD |
2014 | -320000 USD | ? USD |
NRBO
Price: $3.98
52 week price:
Earnings Per Share: -2.46 USD
P/E Ratio: -0.12
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 985600
Market Capitalization: 18.5 million